Heart Test Laboratories (HSCS) Competitors $2.96 +0.05 (+1.72%) Closing price 03:58 PM EasternExtended Trading$3.00 +0.04 (+1.35%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. BSGM, SSKN, LYRA, NURO, WOK, LUCY, IINN, PAVM, MHUA, and POAIShould you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include BioSig Technologies (BSGM), STRATA Skin Sciences (SSKN), Lyra Therapeutics (LYRA), NeuroMetrix (NURO), WORK Medical Technology Group LTD Ordinary Shares (WOK), Innovative Eyewear (LUCY), Inspira Technologies Oxy B.H.N. (IINN), PAVmed (PAVM), Meihua International Medical Technologies (MHUA), and Predictive Oncology (POAI). These companies are all part of the "medical equipment" industry. Heart Test Laboratories vs. BioSig Technologies STRATA Skin Sciences Lyra Therapeutics NeuroMetrix WORK Medical Technology Group LTD Ordinary Shares Innovative Eyewear Inspira Technologies Oxy B.H.N. PAVmed Meihua International Medical Technologies Predictive Oncology Heart Test Laboratories (NASDAQ:HSCS) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, community ranking, media sentiment, analyst recommendations and dividends. Which has more risk and volatility, HSCS or BSGM? Heart Test Laboratories has a beta of 2.77, meaning that its share price is 177% more volatile than the S&P 500. Comparatively, BioSig Technologies has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Which has preferable earnings and valuation, HSCS or BSGM? Heart Test Laboratories has higher earnings, but lower revenue than BioSig Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$14.70K217.67-$6.61M-$7.48-0.40BioSig Technologies$39K218.22-$29.04MN/AN/A Do insiders and institutionals hold more shares of HSCS or BSGM? 17.2% of Heart Test Laboratories shares are held by institutional investors. Comparatively, 7.2% of BioSig Technologies shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by company insiders. Comparatively, 17.0% of BioSig Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer HSCS or BSGM? In the previous week, Heart Test Laboratories had 6 more articles in the media than BioSig Technologies. MarketBeat recorded 6 mentions for Heart Test Laboratories and 0 mentions for BioSig Technologies. Heart Test Laboratories' average media sentiment score of 0.33 beat BioSig Technologies' score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media. Company Overall Sentiment Heart Test Laboratories Neutral BioSig Technologies Neutral Does the MarketBeat Community favor HSCS or BSGM? BioSig Technologies received 97 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 85.71% of users gave Heart Test Laboratories an outperform vote while only 70.55% of users gave BioSig Technologies an outperform vote. CompanyUnderperformOutperformHeart Test LaboratoriesOutperform Votes685.71% Underperform Votes114.29%BioSig TechnologiesOutperform Votes10370.55% Underperform Votes4329.45% Is HSCS or BSGM more profitable? Heart Test Laboratories has a net margin of 0.00% compared to BioSig Technologies' net margin of -44,832.50%. BioSig Technologies' return on equity of 0.00% beat Heart Test Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A -117.76% -84.09% BioSig Technologies -44,832.50%N/A -776.49% Do analysts prefer HSCS or BSGM? Heart Test Laboratories currently has a consensus target price of $13.00, suggesting a potential upside of 339.19%. BioSig Technologies has a consensus target price of $2.75, suggesting a potential upside of 456.91%. Given BioSig Technologies' higher possible upside, analysts plainly believe BioSig Technologies is more favorable than Heart Test Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00BioSig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryHeart Test Laboratories beats BioSig Technologies on 9 of the 15 factors compared between the two stocks. Remove Ads Get Heart Test Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.20M$9.03B$5.74B$8.28BDividend YieldN/A1.41%4.55%4.02%P/E Ratio-0.3717.6524.7019.36Price / Sales217.6769.74396.6193.26Price / CashN/A19.6738.1634.64Price / Book0.275.657.154.51Net Income-$6.61M$284.66M$3.20B$247.14M7 Day Performance-2.95%-0.13%1.84%2.69%1 Month Performance-19.54%-5.13%5.79%-3.39%1 Year Performance-75.33%-19.11%15.10%5.06% Heart Test Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeart Test Laboratories3.0518 of 5 stars$2.96+1.7%$13.00+339.2%-75.8%$3.20M$14,700.00-0.3710Analyst RevisionNews CoverageGap UpBSGMBioSig Technologies1.2885 of 5 stars$0.68+11.5%$2.75+302.0%+2.0%$11.79M$39,000.000.0050Positive NewsGap UpSSKNSTRATA Skin Sciences2.9567 of 5 stars$2.63-5.4%$6.00+128.1%-46.2%$10.97M$32.68M-0.99120Upcoming EarningsNews CoverageGap DownLYRALyra Therapeutics3.2532 of 5 stars$0.17-4.1%$4.50+2,627.3%-97.2%$10.80M$1.47M-0.1150NURONeuroMetrix0.1548 of 5 stars$4.41+0.9%N/A+8.7%$9.05M$3.77M-0.9620WOKWORK Medical Technology Group LTD Ordinary SharesN/A$0.62-3.1%N/AN/A$9.05M$11.51M0.00226Positive NewsGap DownLUCYInnovative Eyewear2.5648 of 5 stars$3.69-0.8%$20.00+442.0%-39.6%$9.01M$1.56M-0.389Earnings ReportGap UpIINNInspira Technologies Oxy B.H.N.0.5307 of 5 stars$0.71-2.7%N/A-55.5%$8.96MN/A0.0020PAVMPAVmed4.0009 of 5 stars$0.76+15.7%$19.00+2,388.2%-62.7%$8.45M$4.03M-0.1890Upcoming EarningsHigh Trading VolumeMHUAMeihua International Medical Technologies0.3803 of 5 stars$0.34+6.7%N/A-56.2%$8.43M$94.25M0.00620Positive NewsPOAIPredictive Oncology1.8322 of 5 stars$1.16+3.6%$3.00+158.6%-58.4%$7.67M$1.48M-0.3830Upcoming EarningsPositive News Remove Ads Related Companies and Tools Related Companies BioSig Technologies Competitors STRATA Skin Sciences Competitors Lyra Therapeutics Competitors NeuroMetrix Competitors WORK Medical Technology Group LTD Ordinary Shares Competitors Innovative Eyewear Competitors Inspira Technologies Oxy B.H.N. Competitors PAVmed Competitors Meihua International Medical Technologies Competitors Predictive Oncology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersThis could put Trump on new $100 billAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.